Matan T. Thangavelu
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Modeling oxaliplatin resistance in colorectal cancer reveals a SERPINE1-based gene signature (RESIST-M) and therapeutic strategies for pro-metastatic CMS4 subtype.
Journal: Cell death & disease
Published: January 08, 2025
CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancer.
Journal: Cell reports. Medicine
Published: July 21, 2024
Genome-wide screens identify specific drivers of mutant hTERT promoters.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 04, 2021
Integrated Genomic Profiling and Drug Screening of Patient-Derived Cultures Identifies Individualized Copy Number-Dependent Susceptibilities Involving PI3K Pathway and 17q Genes in Neuroblastoma.
Journal: Frontiers in oncology
Published: May 14, 2021
Corrigendum to 'A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)'.
Journal: EBioMedicine
Published: April 16, 2021
A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC).
Journal: EBioMedicine
Published: June 17, 2020
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation.
Journal: Nature communications
Published: March 04, 2019
New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation.
Journal: Gastroenterology
Published: January 03, 2019
Longitudinal single-cell RNA sequencing of patient-derived primary cells reveals drug-induced infidelity in stem cell hierarchy.
Journal: Nature communications
Published: August 31, 2018
Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time.
Journal: Nature communications
Published: February 20, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026